Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bispecific”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05079282
What this trial is testing

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

Who this might be right for
Relapsed or Refractory T Cell Lymphoma
Ono Pharmaceutical Co., Ltd. 217
Early research (Phase 1)Looking for participantsNCT07678970
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 10
Early research (Phase 1)Study completedNCT03804996
What this trial is testing

Study of TG-1801 in Subjects With B-Cell Lymphoma

Who this might be right for
B-Cell Lymphoma
TG Therapeutics, Inc. 50
Early research (Phase 1)Study completedNCT03919526
What this trial is testing

Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL

Who this might be right for
MRD-positiveAcute Lymphoblastic Leukemia
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT04889716
What this trial is testing

CAR-T Followed by Bispecific Antibodies

Who this might be right for
Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Abramson Cancer Center at Penn Medicine 23
Testing effectiveness (Phase 2)Looking for participantsNCT07594106
What this trial is testing

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)Clear Cell Renal Cell Carcinoma (ccRCC)
Regeneron Pharmaceuticals 265
Testing effectiveness (Phase 2)Study completedNCT03269526
What this trial is testing

BATs Treatment for Pancreatic Cancer, Phase Ib/II

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
University of Virginia 22
Early research (Phase 1)UnknownNCT03271515
What this trial is testing

Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL

Who this might be right for
LeukemiaLymphoma
Beijing Doing Biomedical Co., Ltd. 20
Not applicableNot Yet RecruitingNCT06766591
What this trial is testing

Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs

Who this might be right for
NSCLCChemotherapyLeptomeningeal Metastases+2 more
Jiangsu Province Nanjing Brain Hospital 36
Testing effectiveness (Phase 2)Looking for participantsNCT05972135
What this trial is testing

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 100
Not applicableStudy completedNCT05529524
What this trial is testing

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 6
Early research (Phase 1)UnknownNCT04763083
What this trial is testing

First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

Who this might be right for
Chronic Lymphocytic LeukaemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4 more
NovalGen Ltd. 90
Large-scale testing (Phase 3)Looking for participantsNCT03643276
What this trial is testing

Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
Martin Schrappe 5,000
Testing effectiveness (Phase 2)Looking for participantsNCT06081478
What this trial is testing

CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic Leukemia

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell LymphomaDiffuse Large B Cell Lymphoma
Beijing Tongren Hospital 100
Large-scale testing (Phase 3)Looking for participantsNCT06091254
What this trial is testing

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Regeneron Pharmaceuticals 822
Early research (Phase 1)Looking for participantsNCT07181369
What this trial is testing

GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

Who this might be right for
Healthy SubjectsCold UrticariaSymptomatic Dermographism+1 more
Granular Therapeutics Limited 72
Early research (Phase 1)Study completedNCT01211262
What this trial is testing

Study to Assess the Tolerability of a Bispecific Targeted Biologic IMCgp100 in Malignant Melanoma

Who this might be right for
Malignant Melanoma
Immunocore Ltd 84
Testing effectiveness (Phase 2)Study completedNCT04276493
What this trial is testing

Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab

Who this might be right for
Breast CancerGastric CancerGastroesophageal Junction Cancer
BeiGene 71
Large-scale testing (Phase 3)Looking for participantsNCT07258511
What this trial is testing

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 400
Large-scale testing (Phase 3)Not Yet RecruitingNCT07724457
What this trial is testing

Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma

Who this might be right for
Recurrent Burkitt LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 RearrangementsRefractory Burkitt Lymphoma+1 more
National Cancer Institute (NCI) 271
Next Page